Vol 10, No 11-12 (2016)

Obtain CPD Credit! CUAJ now provides readers with Section 3 credits of the Maintenance of Certification (self-assessment) program with the RCPSC. Read the accredited article, answer the multiple-choice questionnaire, and log the self-learning activity in your Royal College MAINPORT account.

NEW!

Association des Urologues du Québec
Congrès Annuel 2018 Programme et
Sessions Scientifiques

NEW!
Northeastern Section of the American Urological Association 70th Annual Meeting Program and Abstracts

CLASSIFIED:
McMaster University/McMaster Children's Hospital
Pediatric Urologist
Click here

CLASSIFIED:
Bluewater Health, Sarnia, Ontario
Full-time Urologist
Click here

Hosted By

Part of the
PKP Publishing Services Network

CLASSIFIED:
cmx research partner
Investigators (Urologists) Needed for Clinical Trials
Click here

Vol 10, No 11-12 (2016)

CUAJ December Suppl 7

Table of Contents

Supplement-Introduction

Sunitinib: 10 years of clinical experience in the treatment of advanced renal cell carcinoma

Anil Kapoor

PDF

S235

Supplement-Review

First-line treatment options in metastatic renal cell cancer

Anil Kapoor

PDF

S236-8

Practical first-line management of renal cell carcinoma in a community practice

Henry Conter

PDF

S239-41

Treatment options in advanced renal cell carcinoma after first-line treatment with vascular endothelial growth factor receptor tyrosine kinase inhibitors

Naveen S. Basappa

PDF

S242-4

Sunitinib side effects as surrogate biomarkers of efficacy

Christian Kollmannsberger

PDF

S245-7

Sunitinib toxicity management – a practical approach

Sandeep Sehdev

PDF

S248-51

Can individualized sunitinib dose and schedule changes optimize outcomes for kidney cancer patients?

Georg A. Bjarnason

PDF

S252-5

The next 10 years: Challenges for the future and overcoming resistance to targeted therapies for renal cell carcinoma

Daniel Y.C. Heng

PDF

S256-8

ISSN: 1920-1214